Raydiant Oximetry, a women’s health company, raised $5 million in Series A2 funding, per Fortune’s Term Sheet. Avestria Ventures led the round and was joined by investors including KOFA Healthcare, V-Capital, Band of Angels, FemHealth Ventures, RHIA Ventures, and SteelSky Ventures.
Related Posts
Apollo Medical Holdings Closes CAIPA MSO Strategic Investment
ApolloMed now owns 30% of the post-closing total interests in CAIPA MSO on a fully diluted basis.
August 31, 2021
Brightside Health Raises $50M in Series B
ACME Capital and Mousse Partners led the round.
March 30, 2022
Chiefy Raises $4.2M in Seed Round
LionBird led, with participation from Nina Capital and Emerge Ventures.
April 24, 2023